drospirenone has been researched along with Weight Gain in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (77.78) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antelmi, A; Armani, A; Canese, R; Caprio, M; Carpinelli, G; Cinti, F; Cinti, S; Cranston, GA; Fabbri, A; Malorni, W; Marconi, M; Marzolla, V; Matarrese, P; Morgan, J; Pagotto, U; Quarta, C; Rosano, G; Young, MJ | 1 |
| Short, M | 1 |
| El-Sherbiny, WS; Mohamed, AM; Mostafa, WA | 1 |
| Dickerson, V | 1 |
| Oelkers, W | 1 |
| Marazzi, G; Rosano, GM; Vitale, C; Volterrani, M | 1 |
| Faustmann, T; Foidart, JM | 1 |
| Foidart, JM; Gerlinger, C; Heithecker, R; Huber, J; Merki-Feld, GS; Schellschmidt, I; The, HS; Wuttke, W | 1 |
4 review(s) available for drospirenone and Weight Gain
| Article | Year |
|---|---|
Quality of life issues. Potential role for an oral contraceptive containing ethinyl estradiol and drospirenone.
Topics: Acne Vulgaris; Androgen Antagonists; Androstenes; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Mineralocorticoids; Premenstrual Syndrome; Progesterone Congeners; Quality of Life; Randomized Controlled Trials as Topic; Weight Gain | 2002 |
Drospirenone, a progestogen with antimineralocorticoid properties: a short review.
Topics: Androstenes; Animals; Blood Pressure; Cardiovascular System; Clinical Trials as Topic; Contraceptives, Oral; Drug Interactions; Drug Therapy, Combination; Estrogen Replacement Therapy; Female; Humans; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Progesterone; Rabbits; Rats; Weight Gain | 2004 |
Menopause and cardiovascular disease: the evidence.
Topics: Androstenes; Cardiovascular Diseases; Diabetes Mellitus; Estrogen Replacement Therapy; Female; Humans; Hypertension; Menopause; Mineralocorticoid Receptor Antagonists; Risk Factors; Weight Gain | 2007 |
Advances in hormone replacement therapy: weight benefits of drospirenone, a 17alpha-spirolactone-derived progestogen.
Topics: Androstenes; Attitude to Health; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Estrogens; Female; Humans; Menopause; Patient Compliance; Progesterone Congeners; Renin-Angiotensin System; Water-Electrolyte Balance; Weight Gain | 2007 |
2 trial(s) available for drospirenone and Weight Gain
| Article | Year |
|---|---|
Combined contraceptive ring versus combined oral contraceptive (30-μg ethinylestradiol and 3-mg drospirenone).
Topics: Acne Vulgaris; Adolescent; Adult; Affective Symptoms; Androstenes; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Leukorrhea; Libido; Lipoproteins, LDL; Metrorrhagia; Vaginitis; Weight Gain; Young Adult | 2011 |
Efficacy and tolerability of a monophasic oral contraceptive containing ethinylestradiol and drospirenone.
Topics: Adolescent; Adult; Androstenes; Contraceptives, Oral, Combined; Estradiol Congeners; Ethinyl Estradiol; Europe; Female; Humans; Menstrual Cycle; Mineralocorticoid Receptor Antagonists; Progesterone Congeners; Skin; Weight Gain | 2000 |
3 other study(ies) available for drospirenone and Weight Gain
| Article | Year |
|---|---|
Mineralocorticoid receptor antagonism induces browning of white adipose tissue through impairment of autophagy and prevents adipocyte dysfunction in high-fat-diet-fed mice.
Topics: Adipocytes; Adipogenesis; Adipose Tissue, Brown; Adipose Tissue, White; Aldosterone; Androstenes; Animals; Autophagy; Body Composition; Cell Transdifferentiation; Cells, Cultured; Diet, High-Fat; Female; Gene Expression Profiling; Glucose Intolerance; Inguinal Canal; Intra-Abdominal Fat; Ion Channels; Macrolides; Mice; Mice, Inbred C57BL; Mineralocorticoid Receptor Antagonists; Mitochondrial Proteins; Obesity; Receptors, Mineralocorticoid; Spironolactone; Uncoupling Protein 1; Up-Regulation; Weight Gain | 2014 |
User satisfaction with the combined oral contraceptive drospirenone 3 mg/ethinylestradiol 20 microg (Yasminelle) in clinical practice: a multi-country, questionnaire-based study.
Topics: Adult; Androstenes; Contraceptives, Oral, Combined; Drug Combinations; Drug Eruptions; Ethinyl Estradiol; Female; Humans; Ireland; Menstruation; Patient Satisfaction; Premenstrual Syndrome; Surveys and Questionnaires; Weight Gain; Young Adult | 2009 |
Yasmin--an oral contraceptive with a new progestin.
Topics: Acne Vulgaris; Androstenes; Body Weight; Contraceptive Agents; Contraceptives, Oral, Combined; Female; Humans; Mineralocorticoid Receptor Antagonists; Progesterone Congeners; Progestins; Thromboembolism; Venous Thrombosis; Weight Gain | 2002 |